Prevention of malignant digestive system tumors should focus on the control of chronic inflammation

doi:10.4251/wjgo.v15.i3.389

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2854)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

171

WORD

HTML

1864

Figures (1-2)

195

Sum=2270

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

163

Download

390

Sum=553

Mar 15, 2023 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Mar 15, 2023; 15(3): 389-404
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.389

Full Size Figure Download Figure

Figure 1 Carcinogenic mechanism of malignant digestive system tumors based on chronic inflammation. H. pylori: Helicobacter pylori; CagA: Cytotoxin-associated gene A; VacA: Vacuolating cytotoxin A; OipA: Outer inflammatory protein A; S. typhi: Salmonella Typhi; LPS: Lipopolysaccharide; CDT: Cytolethal distending toxin; E. coli: Escherichia coli; B. fragilis: Bacteroides fragilis; HBV: Hepatitis B virus; HCV: Hepatitis C virus.

Citation: Zhang YH, Chen XL, Wang YR, Hou YW, Zhang YD, Wang KJ. Prevention of malignant digestive system tumors should focus on the control of chronic inflammation. World J Gastrointest Oncol 2023; 15(3): 389-404
URL: https://www.wjgnet.com/1948-5204/full/v15/i3/389.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.389